Please login to the form below

Not currently logged in
Email:
Password:

contraception

This page shows the latest contraception news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

CHMP backs Bayer’s tumour-agnostic drug Vitrakvi

Finally, the panel recommended that Novartis’ multiple sclerosis drug Gilenya (fingolimod) should not be used in pregnant women and in women able to have children who are not using effective contraception

Latest news

More from news
Approximately 10 fully matching, plus 62 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    contraception research and development.

  • The pill branding The pill branding

    In Eastern Europe and Belarus, the positioning rather targets the topic of escape, and in Latin American countries, the brands focus on the very neutral topic of contraception. ... Naming and branding recommendations. Drawing on a branding study we

  • Designing unique patient solutions in rare disease Designing unique patient solutions in rare disease

    She has worked across a range of therapy areas including Psoriasis, Oral Contraception and MS.

  • Pharma deals during June 2013 Pharma deals during June 2013

    Bayer closed its acquisition of Conceptus, securing access to Essure, a non-surgical method of birth control, which extends Bayer's franchise in contraception.  .

  • Pharma deals during January 2013 Pharma deals during January 2013

    This acquisition brings with it an IUD for long term contraception (pending approval in Europe and phase III in the US) and Daifert an immunoassay kit for in vitro fertilisation. ... Acquisition. Contraception fertility. 305. Syncona / Wellcome Trust .

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics